Literature DB >> 29581238

Role of dysfunctional adipocytes in cholesterol-induced nonobese metabolic syndrome.

Jiung-Pang Huang1,2, Sheng-Chieh Hsu1,3, Yaa-Jyuhn James Meir1,4,5, Po-Shiuan Hsieh6, Chih-Chun Chang7, Kuan-Hsing Chen8, Jan-Kan Chen2,9, Li-Man Hung10,2,8.   

Abstract

Many studies have reported the causes of obese metabolic syndrome (MS); however, the causes of nonobese MS (NMS) remain unknown. In this study, we demonstrated that inflamed dysfunctional adipose tissue plays a crucial role in cholesterol-induced NMS. Control (C), high cholesterol (HC) and HC with 10% fructose in drinking water (HCF) diets were fed to Sprague-Dawley rats for 12 weeks. After 12 weeks, the body weights of the C- and HC-fed rats were comparable, but the weights of the HCF-fed rats were relatively low. Cholesterol caused metabolic problems such as high blood pressure, hypercholesterolemia and hypoinsulinemia. The HCF-fed rats exhibited whole-body insulin resistance with low circulating high-density lipoprotein levels. Increases in the tumor necrosis factor α level in the plasma, the number of CD68+ macrophages and the free nuclear factor-κB level in gonadal white adipose tissue (gWAT) resulted in local inflammation, which appeared as inflamed dysfunctional gWAT. Reduced superoxide dismutases (SODs) deteriorate natural antioxidant defense systems and induce reactive oxygen species in gWAT. Dysregulation of plasma levels of catecholamine, adipokines (leptin and adiponectin), hormone-sensitive lipase and perilipin in cholesterol-induced inflamed adipose tissue contributed to increased lipolysis and increased circulating nonesterified fatty acids. Cholesterol activated inflammation, lipolysis and cell death in 3T3-L1 adipocytes. Moreover, Chol-3T3-CM reduced the population of M2-type Raw264.7 macrophages, indicating that the macrophage polarization is mediated by cholesterol. Together, our findings indicate that inflamed dysfunctional adipocytes are critical in NMS, supporting the development of anti-inflammatory agents as potential therapeutic drugs for treating NMS.
© 2018 Society for Endocrinology.

Entities:  

Keywords:  ROS; adipose tissue; cholesterol; inflammation; nonobese metabolic syndrome

Mesh:

Substances:

Year:  2018        PMID: 29581238     DOI: 10.1530/JME-17-0194

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  2 in total

1.  Participation of white adipose tissue dysfunction on circulating HDL cholesterol and HDL particle size in apparently healthy humans.

Authors:  Juan G Juárez-Rojas; Ivan Torre-Villalvazo; Aida X Medina-Urrutia; Juan Reyes-Barrera; Víctor H Sainz-Escárrega; Carlos Posadas-Romero; Alejandro Macías-Cruz; Esteban Jorge-Galarza
Journal:  Int J Obes (Lond)       Date:  2019-12-02       Impact factor: 5.095

2.  In vivo imaging of hemodynamic redistribution and arteriogenesis across microvascular network.

Authors:  Naidi Sun; Bo Ning; Anthony C Bruce; Rui Cao; Scott A Seaman; Tianxiong Wang; Regina Fritsche-Danielson; Leif G Carlsson; Shayn M Peirce; Song Hu
Journal:  Microcirculation       Date:  2019-12-02       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.